Davenport & Co’s Sanofi SNY Stock Holding History

Davenport & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.8M	Sell	2,001,451 -93,511	-4%	-$4.18M	0.42%	80
2026 Q1	$100M	Buy	2,094,962 +52,621	+3%	+$2.45M	0.54%	59
2025 Q4	$99.1M	Sell	2,042,341 -37,653	-2%	-$1.87M	0.53%	62
2025 Q3	$97.4M	Sell	2,079,994 -31,634	-1%	-$1.53M	0.52%	64
2025 Q2	$102M	Sell	2,111,628 -20,464	-1%	-$1.05M	0.55%	56
2025 Q1	$118M	Sell	2,132,092 -163,477	-7%	-$8.85M	0.69%	44
2024 Q4	$111M	Buy	2,295,569 +664,455	+41%	+$33.8M	0.63%	52
2024 Q3	$94M	Buy	1,631,114 +16,267	+1%	+$878K	0.53%	70
2024 Q2	$78.2M	Buy	1,614,847 +65,618	+4%	+$3.17M	0.47%	76
2024 Q1	$75.7M	Buy	1,549,229 +378,860	+32%	+$18.5M	0.46%	80
2023 Q4	$58.1M	Sell	1,170,369 -31,657	-3%	-$1.55M	0.39%	89
2023 Q3	$64.3M	Buy	1,202,026 +10,484	+0.9%	+$559K	0.49%	74
2023 Q2	$63.9M	Buy	1,191,542 +18,656	+2%	+$1M	0.47%	78
2023 Q1	$63.7M	Buy	1,172,886 +1,148,092	+4,631%	+$55.8M	0.5%	70
2022 Q4	$1.2M	Buy	24,794 +369	+2%	+$16.2K	0.01%	466
2022 Q3	$929K	Sell	24,425 -1,239	-5%	-$55.2K	0.01%	510
2022 Q2	$1.28M	Buy	25,664 +118	+0.5%	+$6.26K	0.01%	446
2022 Q1	$1.31M	Buy	25,546 +400	+2%	+$20.7K	0.01%	481
2021 Q4	$1.26M	Buy	25,146 +3,322	+15%	+$164K	0.01%	511
2021 Q3	$1.05M	Buy	21,824 +5,940	+37%	+$302K	0.01%	526
2021 Q2	$836K	Sell	15,884 -55	-0.3%	-$2.87K	0.01%	514
2021 Q1	$788K	Sell	15,939 -7,957	-33%	-$382K	0.01%	431
2020 Q4	$1.16M	Buy	23,896 +871	+4%	+$43K	0.01%	345
2020 Q3	$1.16M	Buy	23,025 +166	+0.7%	+$8.55K	0.01%	317
2020 Q2	$1.17M	Sell	22,859 -496	-2%	-$24.1K	0.01%	308
2020 Q1	$1.02M	Buy	23,355 +2,443	+12%	+$117K	0.01%	286
2019 Q4	$1.05M	Sell	20,912 -3,787	-15%	-$177K	0.01%	335
2019 Q3	$1.07M	Sell	24,699 -225	-0.9%	-$9.7K	0.01%	308
2019 Q2	$1.08M	Buy	24,924 +407	+2%	+$17.3K	0.01%	307
2019 Q1	$1.09M	Sell	24,517 -13,901	-36%	-$595K	0.01%	290
2018 Q4	$1.67M	Buy	38,418 +2,548	+7%	+$112K	0.02%	244
2018 Q3	$1.6M	Sell	35,870 -964	-3%	-$41.2K	0.02%	264
2018 Q2	$1.47M	Sell	36,834 -2,157	-6%	-$84.9K	0.02%	272
2018 Q1	$1.56M	Sell	38,991 -5,433	-12%	-$226K	0.02%	259
2017 Q4	$1.91M	Sell	44,424 -3,363	-7%	-$155K	0.02%	232
2017 Q3	$2.38M	Sell	47,787 -1,179	-2%	-$57.1K	0.03%	197
2017 Q2	$2.35M	Buy	+48,966	New	+$2.34M	0.03%	193
2016 Q4	–	Sell	-897,769	Closed	-$34.3M	–	661
2016 Q3	$34.3M	Buy	897,769 +24,088	+3%	+$967K	0.51%	81
2016 Q2	$36.6M	Sell	873,681 -539	-0.1%	-$22.1K	0.56%	63
2016 Q1	$35.1M	Buy	874,220 +25,008	+3%	+$1M	0.55%	74
2015 Q4	$36.2M	Sell	849,212 -33,736	-4%	-$1.55M	0.59%	64
2015 Q3	$41.9M	Buy	882,948 +16,711	+2%	+$851K	0.7%	48
2015 Q2	$42.9M	Buy	866,237 +19,055	+2%	+$966K	0.67%	51
2015 Q1	$41.9M	Buy	847,182 +818,737	+2,878%	+$39.1M	0.64%	51
2014 Q4	$1.3M	Buy	28,445 +15,061	+113%	+$731K	0.02%	255
2014 Q3	$755K	Sell	13,384 -2,300	-15%	-$124K	0.01%	313
2014 Q2	$834K	Buy	15,684 +884	+6%	+$46.9K	0.01%	297
2014 Q1	$774K	Buy	14,800 +4,150	+39%	+$210K	0.01%	300
2013 Q4	$571K	Sell	10,650 -562	-5%	-$29K	0.01%	348
2013 Q3	$568K	Buy	11,212 +1,045	+10%	+$53.2K	0.01%	330
2013 Q2	$524K	Buy	+10,167	New	+$542K	0.01%	310

Other funds holding SNY

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FBT

First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return

Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

PCM

Palouse Capital Management Spokane, Washington $160M AUM 36.15% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Davenport & Co's SNY Position: Q2 2026 in Review

Davenport & Co reduced its Sanofi (SNY) stake by 4.5% in Q2 2026, selling an estimated $4.18M and leaving 2,001,451 shares worth $85.8M. The position accounts for 0.42% of the portfolio, ranked #80.

Davenport & Co first reported a position in SNY in Q2 2013 and has held it in 51 quarters since. The position peaked at $118M in Q1 2025. 94 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Davenport & Co held 2,001,451 shares of Sanofi worth $85.8M as of Q2 2026.
Davenport & Co sold 93,511 Sanofi shares in Q2 2026, an estimated $4.18M.
Sanofi made up 0.42% of Davenport & Co's portfolio in Q2 2026, its #80 holding.
Davenport & Co first reported a position in Sanofi in Q2 2013 and has held it in 51 quarters since.
Davenport & Co's Sanofi position peaked at $118M in Q1 2025.
94 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.